The sustained release of Dox and a model antibody from the hydrogel was investigated in PBS with or without proteinase K. The capacity of the Dox-loaded hydrogel to cause ICD in B16F10 melanoma cells was revealed by testing the expression of calreticulin (CRT). The gene discussed is CALR; the disease is melanoma.